1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ici 204,219 in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ici 204,219) | Trials (ici 204,219) | Recent Studies (post-2010) (ici 204,219) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 463 | 101 | 91 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | ici 204,219 (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 9.7 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 5.751 | |
| Adenosine receptor A3 | Homo sapiens (human) | 1.363 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.2575 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.363 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.81 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 4.376 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.538 | |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | 2 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.363 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 6.5 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.353 | |
| Cysteinyl leukotriene receptor 1 | Cavia porcellus (domestic guinea pig) | 0.002 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.3 | |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 7.397 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 0.0039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conklyn, M; Showell, HJ; Watson, JW | 1 |
| Barnes, PJ; Chung, KF; Kidney, JC; Ridge, SM | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ici 204,219
| Article | Year |
|---|---|
Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
Topics: Adult; Airway Resistance; Bronchoconstriction; Double-Blind Method; Humans; Indoles; Leukocyte Count; Male; Neutrophils; Phenylcarbamates; Platelet Activating Factor; SRS-A; Sulfonamides; Tosyl Compounds | 1993 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ici 204,219
| Article | Year |
|---|---|
IgG1-mediated acute pulmonary hypersensitivity response in the guinea pig. Involvement of specific lipid mediators.
Topics: Acute Disease; Animals; Azepines; Bronchoconstriction; Dicarboxylic Acids; Dose-Response Relationship, Drug; Furans; Guinea Pigs; Immunization; Immunoglobulin G; Indoles; Lipids; Lung; Male; Ovalbumin; Phenylcarbamates; Piroxicam; Platelet Activating Factor; Propranolol; Pyrilamine; Respiratory Hypersensitivity; SRS-A; Sulfonamides; Tosyl Compounds; Triazoles | 1990 |